Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 placebo-controlled double-blind crossover study of KW-6500 in Parkinson's disease
jRCT2080220980Phase 3
- Sponsor
- Kyowa Kirin
- Start
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of KW-6500 in Parkinson's disease (PD) (2 arms), sponsored by Kyowa Kirin.
02
Drugs
KW-6500
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on jRCT2080220980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220980.